CUV vs EYE

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CUV

CLINUVEL FPO [CUV]

55MEDIUM

EYE

NOVA EYE FPO [EYE]

54MEDIUM

Score Breakdown

CUV EYE
Technical
71
41
Catalyst
52
50
Sentiment
50
50
Fundamental
79
63
Momentum
56
60
Risk Gate
40
45

Key Metrics

CUV Metric EYE
$483.4MMarket Cap$35.6M
113KAvg Volume (20d)340K
+8.2%Short InterestN/A
$14.00052-Week High$0.205
$9.31052-Week Low$0.086
+2.9%Daily Change+4.0%
$9.910Entry Price$0.130
+14.0%ROE-42.4%
+33.8%Profit Margin-21.3%

Active Signals

CUV Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (5.0x)
●Piotroski F-Score strong (8/9, low-confidence approx)

EYE Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 3.7% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.1x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare CUV and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CUV Full Analysis → EYE Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).